Risk factors for hospitalization and death due to COVID-19 among frail community-dwelling elderly people
a retrospective cohort study
Palavras-chave:
Frail elderly, Hospitalization, COVID-19, Risk factors, FrailtyResumo
BACKGROUND: Advanced age, multiple chronic diseases and frailty have been correlated with worse prognosis among coronavirus disease 2019 (COVID-19) inpatients. OBJECTIVE: To investigate potential risk factors for hospitalization and death due to COVID-19 among frail community-dwelling elderly people. DESIGN AND SETTING: Retrospective cohort study of patients followed up at a geriatric outpatient clinic in Belo Horizonte, Minas Gerais, Brazil. METHODS: The associations of demographic characteristics (age and sex) and clinical characteristics (frailty, multimorbidity, number of medications with long-term use, obesity, smoking, diabetes mellitus, pulmonary diseases, cardiovascular diseases, cerebrovascular disease, and chronic kidney disease) with the risk of hospitalization and death due to COVID-19 were explored using a multivariable logistic regression model. RESULTS: 5,295 patients (mean age 78.6 ± 9.4 years; 72.6% females) were included. After adjustments, the number of medications with long-term use was found to increase the odds of hospitalization due to COVID-19 (odds ratio, OR: 1.13; 95% confidence interval, CI: 1.06-1.22). Frailty, multimorbidity and diabetes mellitus also increased the odds of hospitalization (OR: 1.06, 95% CI: 1.02-1.09; OR: 1.17, 95% CI: 1.09-1.26; and OR: 2.27, 95% CI: 1.45-3.54, respectively) and the odds of death due to COVID-19 (OR: 1.07, 95% CI: 1.00-1.14; OR: 1.16, 95% CI: 1.03-1.32; and OR: 2.69, 95% CI: 1.79-6.14, respectively). CONCLUSIONS: Multimorbidity, frailty and diabetes mellitus increased the odds of hospitalization and death due to COVID-19 and the number of medications with long-term use increased the odds of hospitalization due to COVID-19 among frail community-dwelling elderly people.
Downloads
Referências
World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Available from: https://covid19.who.int/ Accessed in 2021 (Dec 21).
Burki T. No end in sight for the Brazilian COVID-19 crisis. Lancet Microbe. 2021;2(5):e180. PMID: 33969328; https://doi.org/10.1016/S2666-5247(21)00095-1.
Chilimuri S, Sun H, Alemam A, et al. Predictors of Mortality in Adults Admitted with COVID-19: Retrospective Cohort Study from New York City. West J Emerg Med. 2020;21(4):779-84. PMID: 32726241; https://doi.org/10.5811/westjem.2020.6.47919.
Aw D, Woodrow L, Ogliari G, Harwood R. Association of frailty with mortality in older inpatients with Covid-19: a cohort study. Age Ageing. 2020;49(6):915-22. PMID: 32778870; https://doi.org/10.1093/ageing/afaa184.
Lippi G, Mattiuzzi C, Sanchis-Gomar F, Henry BM. Clinical and demographic characteristics of patients dying from COVID-19 in Italy vs China. J Med Virol. 2020; 92(10):1759-60. PMID: 32275075; https://doi.org/10.1002/jmv.25860.
Figliozzi S, Masci PG, Ahmadi N, et al. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis. Eur J Clin Invest. 2020;50(10): e13362. PMID: 32726868; https://doi.org/10.1111/eci.13362.
Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752-62. PMID: 23395245; https://doi.org/10.1016/S0140-6736(12)62167-9.
Ma Y, Hou L, Yang X, et al. The association between frailty and severe disease among COVID-19 patients aged over 60 years in China: a prospective cohort study. BMC Med. 2020;18(1):274. PMID: 32892742; https://doi.org/10.1186/s12916-020-01761-0.
Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7(4):357-63. PMID: 19597174; https://doi.org/10.1370/afm.983.
Ji D, Zhang D, Xu J, et al. Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score. Clin Infect Dis. 2020;71(6):1393-9. PMID: 32271369; https://doi.org/10.1093/cid/ciaa414.
Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91-5. PMID: 32173574; https://doi.org/10.1016/j.ijid.2020.03.017.
World Health Organization. Advice for the public: Coronavirus disease (COVID-19). 2021. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public Accessed in 2021 (Dec 21).
Andrade MV, Noronha K, Turra CM, et al. Os primeiros 80 dias da pandemia da COVID-19 em Belo Horizonte: da contenção à flexibilização [The first 80 days of the COVID-19 pandemic in the city of Belo Horizonte: from containment to reopening]. Nova econ. 2020;30(2):701-37. https://doi.org/10.1590/0103-6351/6302.
Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-42. PMID: 32091533; https://doi.org/10.1001/jama.2020.2648.
Moraes EN, Carmo JA, Moraes FL, et al. Clinical-Functional Vulnerability Index-20 (IVCF-20): rapid recognition of frail older adults. Rev Saude Publica. 2016;50:81. PMID: 28099667; https://doi.org/10.1590/S1518-8787.2016050006963.
Huntley AL, Johnson R, Purdy S, Valderas JM, Salisbury C. Measures of multimorbidity and morbidity burden for use in primary care and community settings: a systematic review and guide. Ann Fam Med. 2012;10(2):134-41. PMID: 22412005; https://doi.org/10.1370/afm.1363.
World Health Organization Expert Committee. Physical Status: the Use and Interpretation of Anthropometry (1993: Geneva, Switzerland) & World Health Organization. (1995). Physical status: the use of and interpretation of anthropometry, report of a WHO expert committee. World Health Organization. Available from: https://apps.who.int/iris/handle/10665/37003 Accessed in 2021 (Dec 21).
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-62. PMID: 32171076; https://doi.org/10.1016/S0140-6736(20)30566-3. Erratum in: Lancet. 2020;395(10229):1038.
Guo Y, Liu X, Deng M, et al. Epidemiology of COVID-19 in older persons, Wuhan, China. Age Ageing. 2020;49(5):706-12. PMID: 32584953; https://doi.org/10.1093/ageing/afaa145.
Bonanad C, García-Blas S, Tarazona-Santabalbina F, et al. The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects. J Am Med Dir Assoc. 2020;21(7):915-8. PMID: 32674819; https://doi.org/10.1016/j.jamda.2020.05.045.
Hewitt J, Carter B, Vilches-Moraga A, et al. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. Lancet Public Health. 2020;5(8):e444-e451. PMID: 32619408; https://doi.org/10.1016/S2468-2667(20)30146-8.
Noor FM, Islam MM. Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis. J Community Health. 2020;45(6):1270-82. PMID: 32918645; https://doi.org/10.1007/s10900-020-00920-x.
Iaccarino G, Grassi G, Borghi C, et al. Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension. Hypertension. 2020;76(2):366-72. PMID: 32564693; https://doi.org/10.1161/HYPERTENSIONAHA.120.15324.
Song J, Park DW, Cha JH, et al. Clinical course and risk factors of fatal adverse outcomes in COVID-19 patients in Korea: a nationwide retrospective cohort study. Sci Rep. 2021;11(1):10066. PMID: 33980912; https://doi.org/10.1038/s41598-021-89548-y.
Ioannou GN, Locke E, Green P, et al. Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection. JAMA Netw Open. 2020;3(9):e2022310. PMID: 32965502; https://doi.org/10.1001/jamanetworkopen.2020.22310.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
